Cortefin®

Triamcinolone

Prescribing Details



Description
Cortefin ® is the preparation of Triamcinolone Acetonide. Triamcinolone Acetonide is a synthetic topical corticosteroid which has anti-inflammatory, antipruritic and vasoconstrictive effects.

Uses
No Data

Indications
Cortefin ® is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses including atopic dermatitis, contact dermatitis, eczematous dermatitis, neurodermatitis, seborrheic dermatitis, insect bites, lichen simplex chronicus, exfoliative dermatitis, stasis dermatitis, nummular eczema, psoriasis and pruritus ani and vulvae.

Dosage and administration
A small amount of Cortefin ® is gently rub to the affected area 1-2 times daily.

Some cases of eczematised psoriasis may be treated more effectively by the application ofCortefin ® under an occlusive dressing.
Occlusive dressing technique: Gently rub a small amount of Cortefin ® on the lesion until it disappears. Then reapply, leaving a thin coating and cover with a pliable non porous film. For convenience apply Cortefin ® intermittently (12 hour occlusion during the night) followed by reapplication without occlusion, during the day.

Pediatric use
Cortefin ® should not be used in children under 8 years. Administration of topical corticosteroids to children should be limited to the least amount compatible with an effective therapeutic regimen. Chronic corticosteroid therapy may interfere with the growth and development of children. As children are more likely to get side effects, they should not normally be treated for longer than 5 days.

Use in pregnancy & lactation
There are no adequate and well-controlled studies in pregnant women on teratogenic effects from topically applied corticosteroids. Therefore, topical corticosteroid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether topical administration of corticosteroid could result in sufficient systemic absorption to produce detectable quantities in breast milk. Systemically administered corticosteroids are secreted into breast milk in quantities not likely to have a deleterious effect on the infant. Nevertheless, caution should be exercised when topical corticosteroids are administered to a nursing woman.

Geriatric use
No Data

Precautions
If reactions or idiosyncrasies are encountered, Triamcinolone Acetonide should be discontinued. The use of topical steroids on infected areas should be attended with caution and careful observation, bearing in mind the potential spreading of infections by anti-inflammatory steroids and the possible advisability of discontinuing steroid therapy and/or initiating antibacterial measures.

Warning
Triamcinolone Acetonide should not be used on healthy skin or over large areas of skin and not to be used in the eye as there is potential risk of glaucoma and cataract. When steroids are applied for longperiods of time (more than 4 weeks) the occurrence of atrophic striae is likely. Prolonged use on flexures and intertriginous areas is undesirable. Children may absorb proportionately largeramounts of topical corticosteroids and thus may be more susceptible to systemic toxicity. In infants, long term continuous topical steroid therapy should be avoided. Adrenal suppression can occur even without occlusion.

Side effects
The following local side effects have been reported with topical corticosteroids, either with or without occlusive dressings: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis and allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae and miliaria.

Contraindications
Triamcinolone Acetonide is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. It is also contraindicated in tuberculosis ofthe skin, fungus infections and viral diseases of the skin (Herpes simplex, chickenpox and vaccinia), perioral dermatitis, rosacea and ulcerative conditions.

Drug interactions
No Data

Overdose
Topically applied corticosteroids can be absorbed in sufficient amounts to produce systemic effects e.g., mild, reversible suppression of adrenal function, ecchymoses of the skin, peptic ulceration, hypertension, aggravation of infection, hirsutism, acne, edema and muscle weakness.

Preparation
No Data

Pharmaceutical precautions
Store in a cool & dry place. Protect from light.

Presentation
Cortefin ® cream: Each gram cream contains Triamcinolone Acetonide BP 1 mg.
Cortefin ® ointment: Each gram ointment contains Triamcinolone Acetonide BP 1 mg.

Package quantitie
Cortefin ® cream: Tube of 10 g.
Cortefin ® ointment: Tube of 10 g.